Over-prescription of short-acting β₂-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study

References

• Global Initiative for Asthma [Internet]. Global strategy for asthma management and prevention; 2022 [cited 2022 Jun 17]. Available from: http://ginasthma.org/.
   Google Scholar
• Global Asthma Network (GAN) [Internet]. The global asthma report; 2018 [cited 2021 Jun 22]. Available from: http://www.globalasthmareport.org.
   Google Scholar
• Adeloye D, Chan KY, Rudan I, et al. An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J. 2013;54(6):519–531.
   PubMed Web of Science ®Google Scholar
• World Health Organization [Internet]. Asthma, key facts; 2021 [cited 2021 Jun 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma.
   Google Scholar
• Aldridge RE, Hancox RJ, Robin Taylor D, et al. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Respir Crit Care Med. 2000;161(5):1459–1464.
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50(3):1701103.
   PubMed Web of Science ®Google Scholar
• Cabrera CS, Nan C, Lindarck N, et al. SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma. Eur Respir J. 2020;55(2):1901858.
   PubMed Web of Science ®Google Scholar
• Bloom CI, Cabrera C, Arnetorp S, et al. Asthma-related health outcomes associated with short-acting β2-agonist use: an observational UK study as part of the SABINA global program. Adv Ther. 2020;37(10):4190–4208.
   PubMed Web of Science ®Google Scholar
• Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872.
   PubMed Web of Science ®Google Scholar
• Silver HS, Blanchette CM, Kamble S, et al. Relationship between short-acting β2-adrenergic agonist use and healthcare costs. Am J Manag Care. 2011;17(1):19–27.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–47.
   PubMed Web of Science ®Google Scholar
• Onyedum C, Ukwaja K, Desalu O, et al. Challenges in the management of bronchial asthma among adults in Nigeria: a systematic review. Ann Med Health Sci Res. 2013;3(3):324–329.
   PubMedGoogle Scholar
• Tarraf H, Al-Jahdali H, Al Qaseer AH, et al. Asthma control in adults in the Middle East and North Africa: results from the ESMAA study. Respir Med. 2018;138:64–73.
   PubMed Web of Science ®Google Scholar
• Anandan C, Nurmatov U, van Schayck OC, et al. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65(2):152–167.
   PubMed Web of Science ®Google Scholar
• Asher I, Bissell K, Chiang CY, et al. Calling time on asthma deaths in tropical regions-how much longer must people wait for essential medicines? Lancet Respir Med. 2019;7(1):13–15.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Price D, Wang HC, et al. Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study. Eur Respir J. 2022;59(5):2101402.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma [Internet]. Global strategy for asthma management and prevention; 2017 [cited 2021 Jun 22]. Available from: http://ginasthma.org/.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99.
   PubMed Web of Science ®Google Scholar
• World Economic Forum [Internet]. 19 Of the world’s 20 youngest countries are in Africa; 2019 [cited 2021 Jun 22]. Available from: https://www.weforum.org/agenda/2019/08/youngest-populations-africa/.
   Google Scholar
• Office of the Special Adviser on Africa [Internet]. Youth empowerment; 2021 [cited 2021 Jun 22]. Available from: https://www.un.org/osaa/.
   Google Scholar
• Haouichat H, Benali R, Benyounes A, et al. Asthma control in adult Algerian patients. Comparison with other North African and Middle-East countries. Rev Mal Respir. 2020;37(1):15–25.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, National Heart, Lung, and Blood Institute's Severe Asthma Research Program, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315–323.
   PubMed Web of Science ®Google Scholar
• Zemedkun K, Woldemichael K, Tefera G. Assessing control of asthma in Jush, Jimma, South West Ethiopia. Ethiop J Health Sci. 2014;24(1):49–58.
   PubMedGoogle Scholar
• Braman SS. The global burden of asthma. Chest. 2006;130(1 Suppl):4S–12S.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services [Internet]. Office of disease prevention and health promotion. Acces to health services; 2022 [cited 2022 Jun 17]. https://www.healthypeople.gov/2020/leading-health-indicators/2020-lhi-topics/Access-to-Health-Services/data.
   Google Scholar
• Macha J, Harris B, Garshong B, et al. Factors influencing the burden of health care financing and the distribution of health care benefits in Ghana, Tanzania and South Africa. Health Policy Plan. 2012;27(Suppl 1):i46–i54.
   PubMed Web of Science ®Google Scholar
• Department of Health, Republic of South Africa [Internet]. National health insurance for South Africa – towards universal health coverage; 2021 [cited 2021 Jun 22]. Available from: https://www.gov.za/sites/default/files/gcis_document/201707/40955gon627.pdf.
   Google Scholar
• Ferris TG, Blumenthal D, Woodruff PG, MARC Investigators, et al. Insurance and quality of care for adults with acute asthma. J Gen Intern Med. 2002;17(12):905–913.
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
   PubMedGoogle Scholar
• Douglass JA, Goeman DP, McCarthy EA, et al. Over-the-counter β2-agonist purchase versus script: a cross-sectional study. Respir Med. 2012;106(2):223–229.
   PubMed Web of Science ®Google Scholar
• Campbell D, Ruffin R, Wilson D, et al. Over-the-counter purchase of inhaled β2-agonists: a qualitative study of asthma patients. Health Promot J Austr. 2000;10:38–42.
   Google Scholar
• Gibson P, Henry D, Francis L, et al. Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma. BMJ. 1993;306(6891):1514–1518.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Ampon RD, Sawyer SM, et al. Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey. BMJ Open. 2017;7(9):e016688.
   PubMed Web of Science ®Google Scholar
• Henry DA, Sutherland D, Francis L. The use of non-prescription salbutamol inhalers by asthmatic patients in the hunter valley, New South Wales. Newcastle Retail Pharmacy Research Group. Med J Aust. 1989;150(8):445–449.
   PubMed Web of Science ®Google Scholar
• Babar ZU, Lessing C, Mace C, et al. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics. 2013;31(11):1063–1082.
   PubMed Web of Science ®Google Scholar
• Kibirige D, Sanya RE, Nantanda R, et al. Availability and affordability of medicines and diagnostic tests recommended for management of asthma and chronic obstructive pulmonary disease in Sub-Saharan Africa: a systematic review. Allergy Asthma Clin Immunol. 2019;15:14.
   PubMed Web of Science ®Google Scholar
• Sanyang B, Jagne E, Sefa N, et al. Availability, cost, and affordability of asthma and chronic obstructive pulmonary disease medications in the Gambia. JPATS. 2021;2(1):33–41.
   Google Scholar
• Gerald JK, Carr TF, Wei CY, et al. Albuterol overuse: a marker of psychological distress? J Allergy Clin Immunol Pract. 2015;3(6):957–962.
   PubMed Web of Science ®Google Scholar
• Patel M, Pilcher J, Reddel HK, SMART Study Group, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy. 2013;43(10):1144–1151.
   PubMed Web of Science ®Google Scholar
• Stanford RH, Shah MB, D'Souza AO, et al. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109(6):403–407.
   PubMed Web of Science ®Google Scholar
• Nguyen VN, Nguyen QN, Le An P, et al. Implementation of GINA guidelines in asthma management by primary care physicians in vietnam. Int J Gen Med. 2017;10:347–355.
   PubMed Web of Science ®Google Scholar
• Fawibe AE, Onyedum CC, Sogaolu OM, et al. Drug prescription pattern for asthma among Nigerian doctors in general practice: a cross-sectional survey. Ann Thorac Med. 2012;7(2):78–83.
   PubMed Web of Science ®Google Scholar
• Kirenga JB, Okot-Nwang M. The proportion of asthma and patterns of asthma medications prescriptions among adult patients in the chest, accident and emergency units of a tertiary health care facility in Uganda. Afr Health Sci. 2012;12(1):48–53.
   PubMed Web of Science ®Google Scholar
• Chikaodinaka Ayuk A, Ubesie A, Laura Odimegwu C, et al. Use of global initiative for asthma (GINA) guidelines in asthma management among paediatric residents in a Sub Saharan African country: a cross-sectional descriptive study. Pan Afr Med J. 2017;27:120.
   PubMed Web of Science ®Google Scholar
• Verwey C. The national asthma education programme and asthma in Africa. S Afr Med J. 2019;109(7):453–454.
   PubMed Web of Science ®Google Scholar
• Manderson L. Prescribing, care and resistance: antibiotic use in urban South Africa. Humanit Soc Sci Commun. 2020;7(1):77.
   Google Scholar
• Normansell R, Sayer B, Waterson S, et al. Antibiotics for exacerbations of asthma. Cochrane Database Syst Rev. 2018;6:CD002741.
   PubMed Web of Science ®Google Scholar
• Akpan MR, Isemin NU, Udoh AE, et al. Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020;22:317–324.
   PubMed Web of Science ®Google Scholar
• World Health Organization [Internet]. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit; 2021 [cited 2021 Jun 22]. https://apps.who.int/iris/handle/10665/329404.
   Google Scholar
• Brink AJ, Messina AP, Feldman C, et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis. 2016;16(9):1017–1025.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Thompson PJ, Price D, et al. Taking aim at asthma around the world: global results of the asthma insight and management survey in the Asia-Pacific region, Latin America, Europe, Canada, and the United States. J Allergy Clin Immunol Pract. 2015;3(5):734–742 e5.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, O'Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887.
   PubMed Web of Science ®Google Scholar
• Ding B, Small M. Disease burden of mild asthma: findings from a cross-sectional real-world survey. Adv Ther. 2017;34(5):1109–1127.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Barnes PJ, Chipps BE, et al. The burden of exacerbations in mild asthma: a systematic review. ERJ Open Res. 2020;6(3):00359-2019.
   PubMedGoogle Scholar
• Baddar S, Jayakrishnan B, Al-Rawas O, et al. Is clinical judgment of asthma control adequate?: a prospective survey in a tertiary hospital pulmonary clinic. SQUMJ. 2013;13(1):63–68.
   Google Scholar
• Martins P, Rosado-Pinto J, do Céu Teixeira M, et al. Under-report and underdiagnosis of chronic respiratory diseases in an African country. Allergy. 2009;64(7):1061–1067.
   PubMed Web of Science ®Google Scholar
• van Gemert F, van der Molen T, Jones R, et al. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20(3):240–248.
   PubMedGoogle Scholar
• Jumbe Marsden E, Wa Somwe S, Chabala C, et al. Knowledge and perceptions of asthma in Zambia: a cross-sectional survey. BMC Pulm Med. 2016;16:33.
   PubMed Web of Science ®Google Scholar
• Roche N, Reddel H, Martin R, Respiratory Effectiveness Group, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014;11(Suppl 2):S99–S104.
   PubMedGoogle Scholar
• Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1S):S65–S71.
   PubMed Web of Science ®Google Scholar